About
Technology
Issues
FAQ
Links
Official Page
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.